磁驱动生长棒治疗早发性脊柱侧凸5年成本分析
前瞻性病例系列纳入9例早发性脊柱侧凸(EOS)患儿,由单一术者采用磁驱动生长棒(MdGR)治疗,从付费方角度计算人均付费成本(PC),并与文献报告的常规生长棒(CGR)5年PC比较。MdGR人均PC为£34,741,CGR为£52,293,MdGR成本效益至少高40%;MdGR单独占总体预算至少50%,7例完成MdGR治疗。
要点
- 9例EOS患儿接受MdGR治疗,MdGR人均付费成本£34,741,CGR文献报告为£52,293。
- MdGR较CGR成本效益至少高40%,MdGR单独占总体预算至少50%。
- 7例完成MdGR治疗;作者认为MdGR是有前景的新型植入物,可能最终成为某些EOS病因的标准治疗。
核心结论
- 首次报告MdGR治疗EOS的直接付费成本,未采用数学建模和确定性敏感性分析。
- 考虑间接成本后,真实社会/人力成本节约可能显著更高。
- MdGR是有前景的新型植入物,可能最终成为某些EOS病因的标准治疗。
研究设计与样本
- 前瞻性病例系列,纳入9例早发性脊柱侧凸(EOS)患儿,由单一术者行MdGR肌下置入。
- EOS病因包括特发性2例、先天性1例、综合征性3例和神经肌肉性3例。
- 从付费方角度收集器械使用寿命内(或至少5年)所有方面护理产生的成本,计算并报告人均付费成本(PC)。
- 将MdGR的PC与文献报告的CGR 5年PC进行比较。
主要发现
- 5例为单棒(SR)de novo MdGR置入,2例为双棒(DR)de novo MdGR置入,2例为CGR转换为MdGR。
- MdGR单独占总体预算至少50%。
- MdGR人均PC为£34,741,CGR文献报告PC为£52,293,MdGR成本效益至少高40%。
- 7例完成MdGR治疗。
关键数值与推荐
- MdGR单独占总体预算至少50%。
- 证据等级:4级。
临床怎么用
- 原文未据此给出推荐。
局限性
- CGR的付费成本来自文献报告而非同一队列直接比较。
- 样本量小(9例)。
- 证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Prospective case series of nine children with early-onset scoliosis (EOS) treated by a single surgeon with a novel implant, the magnet-driven growing rod (MdGR) in a publicly funded health care service accounting for "payer costs" (PC) incurred. OBJECTIVE: The aim of this study was to compare the cost-effectiveness of MdGR versus conventional growing rods (CGRs) with respect to the PC incurred for treating EOS at 5 years. SUMMARY OF BACKGROUND DATA: Cost estimate and mathematical modeling study projections of MdGR have shown despite high insertional costs, it breaks even with CGR by 3 to 4 years. However, no clinical study to date exists either supporting or refuting this hypothesis. METHODS: Nine patients with EOS secondary to idiopathic (two), congenital (one), syndromic (three), and neuromuscular (three) etiologies treated by submuscular insertion of MdGR against stringent inclusion criteria formed the study cohort. We collected costs incurred with all aspects of care over the lifetime of device (or at least 5 years) from payers' perspective to compute and report average PC incurred per patient. We performed this cost analysis by comparing the MdGR PC against literature reported PC for CGR at 5 years. RESULTS: There were five single rod (SR) and two dual rod (DR) de novo MdGR insertions, while two patients had conversion of CGR to MdGR. MdGR alone accounted for at least 50% of overall budget. The MdGR was at least 40% more cost-effective in comparison to the CGR (£34,741 vs. £52,293) and there were seven MdGR graduates. CONCLUSION: The first study reporting direct PC incurred in EOS treated by MdGR that is devoid of any mathematical modeling and deterministic sensitivity analysis is presented. The true societal/human cost savings taking into consideration indirect costs are likely to be significantly higher. MdGR is a promising novel implant that may eventually become the "standard of care" for certain EOS etiologies. LEVEL OF EVIDENCE: 4.
引用
- Harshavardhana NS, Noordeen MHH, Dormans JP, et al. Cost Analysis of Magnet-driven Growing Rods for Early-onset Scoliosis at 5 Years. Spine (Phila Pa 1976). 2019. PMID: 29894450. doi:10.1097/BRS.0000000000002738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。